ASX:MDC

Medlab Clinical (MDC) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
36,677 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MDC stock logo

About Medlab Clinical Stock (ASX:MDC)

Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Botany, Australia.

MDC Stock News Headlines

Clinical Laboratory Technician Salary
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
Medlab Clinical Ltd. Files to List on Nasdaq
Medlab Clinical Ltd
M.D.C. Holdings, Inc. (MDC)
Miami Dade College User Reviews
Nanocelle® Patent Granted in Usa
NANOCELLE “ISSUE OF ALLOWANCE” BY US PATENT OFFICE
Medlab Clinical Ltd (MDC)
Medlab Clinical Limited (MDC.AX)
See More Headlines
Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medlab Clinical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,773
Year Founded
N/A

Profitability

Net Income
$-8,920,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.66 million
Book Value
A$1.42 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.90
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Dr. Sean Michael Hall (Age 54)
    MD, CEO & Director
    Comp: $574.11k
  • Mr. Kerem Kaya (Age 51)
    CFO, COO & Company Secretary
    Comp: $292.83k
  • Dr. David A. Rutolo ­ (USA)
    J.D., Ph.D., Director of Science
  • Mr. Ian Curtinsmith
    Chief Information Officer

MDC Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Medlab Clinical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medlab Clinical investors own include iSignthis (ISX), FBR (FBR), Embark Early Education (EVO), Dacian Gold (DCN), Constellation Technologies (CT1), Bod Australia (BDA), Afterpay (APT), Alkane Resources (ALK) and AusCann Group (AC8).

This page (ASX:MDC) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners